Jing Lu

Also affiliated with Io Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Targeting of HIF2-driven cachexia in kidney cancer”.

Targeting of HIF2-driven cachexia in kidney cancer

Nature Medicine(2025)10.1038/s41591-025-04054-2

N/A

0.419DataRank · unranked

9 citations

Laura Stransky, Nikita Bhalerao, Nitin H. Shirole, Qinqin Jiang, Eddy Saad +15 more

HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.09.675147

N/A

0DataRank · unranked

1 citations

Laura Stransky, Nikita Bhalerao, Nitin H. Shirole, Qinqin Jiang, Eddy Saad +15 more